Canada Life’s Glaukos GKOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.16M | Sell |
47,913
-2,188
| -4% | -$246K | 0.01% | 736 |
|
|
2025
Q4 | $5.66M | Sell |
50,101
-11,247
| -18% | -$1.07M | 0.01% | 703 |
|
|
2025
Q3 | $4.99M | Buy |
61,348
+514
| +0.8% | +$47.2K | 0.01% | 814 |
|
|
2025
Q2 | $6.29M | Buy |
60,834
+1,000
| +2% | +$93.8K | 0.01% | 702 |
|
|
2025
Q1 | $5.89M | Sell |
59,834
-5,095
| -8% | -$680K | 0.01% | 729 |
|
|
2024
Q4 | $9.75M | Buy |
64,929
+601
| +0.9% | +$82.8K | 0.02% | 572 |
|
|
2024
Q3 | $8.38M | Buy |
64,328
+3,104
| +5% | +$386K | 0.01% | 631 |
|
|
2024
Q2 | $7.24M | Buy |
61,224
+5,335
| +10% | +$566K | 0.01% | 649 |
|
|
2024
Q1 | $5.26M | Buy |
55,889
+3,565
| +7% | +$319K | 0.01% | 785 |
|
|
2023
Q4 | $4.15M | Sell |
52,324
-1,018
| -2% | -$69.4K | 0.01% | 860 |
|
|
2023
Q3 | $4.01M | Buy |
53,342
+574
| +1% | +$42.9K | 0.01% | 837 |
|
|
2023
Q2 | $3.76M | Sell |
52,768
-2,533
| -5% | -$145K | 0.01% | 861 |
|
|
2023
Q1 | $2.77M | Sell |
55,301
-3,144
| -5% | -$153K | 0.01% | 1065 |
|
|
2022
Q4 | $2.56M | Buy |
58,445
+992
| +2% | +$48.9K | 0.01% | 1103 |
|
|
2022
Q3 | $3.06M | Buy |
57,453
+10,982
| +24% | +$567K | 0.01% | 924 |
|
|
2022
Q2 | $2.11M | Buy |
46,471
+6,044
| +15% | +$287K | 0.01% | 1135 |
|
|
2022
Q1 | $2.4M | Buy |
40,427
+167
| +0.4% | +$8.84K | 0.01% | 1113 |
|
|
2021
Q4 | $1.79M | Buy |
40,260
+719
| +2% | +$33.2K | ﹤0.01% | 1252 |
|
|
2021
Q3 | $1.92M | Hold |
39,541
| – | – | ﹤0.01% | 1209 |
|
|
2021
Q2 | $3.35M | Buy |
39,541
+436
| +1% | +$35.8K | 0.01% | 842 |
|
|
2021
Q1 | $3.27M | Sell |
39,105
-4,326
| -10% | -$380K | 0.01% | 845 |
|
|
2020
Q4 | $3.27M | Sell |
43,431
-5,664
| -12% | -$358K | 0.01% | 907 |
|
|
2020
Q3 | $2.43M | Buy |
49,095
+857
| +2% | +$37.7K | 0.01% | 967 |
|
|
2020
Q2 | $1.85M | Sell |
48,238
-3,285
| -6% | -$122K | ﹤0.01% | 1118 |
|
|
2020
Q1 | $1.59M | Buy |
51,523
+49,111
| +2,036% | +$2.52M | ﹤0.01% | 1066 |
|
|
2019
Q4 | $131K | Buy |
+2,412
| New | +$147K | ﹤0.01% | 2021 |
|
|
2019
Q3 | – | Sell |
-4,271
| Closed | -$321K | – | 1578 |
|
|
2019
Q2 | $321K | Buy |
4,271
+31
| +0.7% | +$2.22K | ﹤0.01% | 1911 |
|
|
2019
Q1 | $331K | Hold |
4,240
| – | – | ﹤0.01% | 1751 |
|
|
2018
Q4 | $230K | Hold |
4,240
| – | – | ﹤0.01% | 1895 |
|
|
2018
Q3 | $275K | Hold |
4,240
| – | – | ﹤0.01% | 1893 |
|
|
2018
Q2 | $172K | Buy |
4,240
+2,240
| +112% | +$79.7K | ﹤0.01% | 2022 |
|
|
2018
Q1 | $62K | Hold |
2,000
| – | – | ﹤0.01% | 2312 |
|
|
2017
Q4 | $51K | Hold |
2,000
| – | – | ﹤0.01% | 2357 |
|
|
2017
Q3 | $66K | Hold |
2,000
| – | – | ﹤0.01% | 2267 |
|
|
2017
Q2 | $83K | Hold |
2,000
| – | – | ﹤0.01% | 2168 |
|
|
2017
Q1 | $102K | Buy |
+2,000
| New | +$87.2K | ﹤0.01% | 2109 |
|
Other funds holding GKOS
VPM
VCM
Canada Life's GKOS Position: Q1 2026 in Review
Canada Life reduced its Glaukos (GKOS) stake by 4.4% in Q1 2026, selling an estimated $246K and leaving 47,913 shares worth $5.16M. The position accounts for 0.01% of the portfolio, ranked #736.
Canada Life first reported a position in GKOS in Q1 2017 and has held it in 36 quarters since. The position peaked at $9.75M in Q4 2024. 336 funds tracked by Wall St. Rank hold GKOS as of Q1 2026.
- Canada Life held 47,913 shares of Glaukos worth $5.16M as of Q1 2026.
- Canada Life sold 2,188 Glaukos shares in Q1 2026, an estimated $246K.
- Glaukos made up 0.01% of Canada Life's portfolio in Q1 2026, its #736 holding.
- Canada Life first reported a position in Glaukos in Q1 2017 and has held it in 36 quarters since.
- Canada Life's Glaukos position peaked at $9.75M in Q4 2024.
- 336 funds tracked by Wall St. Rank held Glaukos as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.